日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Implementation Science to Improve the Diagnosis and Management of Hidradenitis Suppurativa: HELyx Study Design Overview

实施科学在改善化脓性汗腺炎诊断和治疗中的应用：HELyx 研究设计概述

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01350-0
Ingram, John R; Kokolakis, Georgios; McGrath, Barry M; Romanelli, Marco; Bechara, Falk G; Martorell, Antonio; Biermann, Mona; Geissbühler, Yvonne; Haeberle, Benjamin M; Zahid, Mahrukh; Fritz, Michael; Quebe-Fehling, Erhard; Richardson, Craig; Becherel, Pierre-André
发表日期：2025
文献求助 收藏

Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab

中轴型脊柱关节炎或银屑病关节炎患者的葡萄膜炎：一项来自安慰剂对照 III 期司库奇尤单抗研究的事后分析

期刊:Therapeutic Advances in Musculoskeletal Disease
影响因子:4.1
doi:10.1177/1759720X251340255
Brandt-Jürgens, Jan; Rudwaleit, Martin; Behrens, Frank; Ritchlin, Christopher; Peterlik, Daniel; Quebe-Fehling, Erhard; Deodhar, Atul
关节炎
银屑病
发表日期：2025
文献求助 收藏

Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy

在早期类风湿性关节炎中，巴瑞替尼单药治疗或联合甲氨蝶呤治疗与甲氨蝶呤单药治疗相比，在控制疼痛方面的效果如何？

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2021-001994
Taylor, Peter C; Alten, Rieke; Álvaro Gracia, Jose María; Kaneko, Yuko; Walls, Chad; Quebe, Amanda; Jia, Bochao; Bello, Natalia; Terres, Jorge Ross; Fleischmann, Roy
关节炎
发表日期：2022
文献求助 收藏

Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications

司库奇尤单抗对传统心血管危险因素和炎症生物标志物的影响：三个适应症汇总数据的事后分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-022-00434-z
Merola, Joseph F; McInnes, Iain B; Deodhar, Atul A; Dey, Amit K; Adamstein, Nicholas H; Quebe-Fehling, Erhard; Aassi, Maher; Peine, Michael; Mehta, Nehal N
炎症/感染
炎症
发表日期：2022
文献求助 收藏

Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis-going beyond treat to target

行动呼吁：将健康养生实践纳入类风湿性关节炎的整体管理计划——超越单纯治疗，达到最佳疗效

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2021-001959
Taylor, Peter C; Van de Laar, Mart; Laster, Andrew; Fakhouri, Walid; Quebe, Amanda; de la Torre, Inmaculada; Jain, Saundra
关节炎
发表日期：2021
文献求助 收藏

Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies

在活动性强直性脊柱炎患者中使用司库奇尤单抗治疗 3 年达到缓解终点：两项 3 期研究的汇总分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-020-00269-6
Baraliakos, Xenofon; Van den Bosch, Filip; Machado, Pedro M; Gensler, Lianne S; Marzo-Ortega, Helena; Sherif, Bintu; Quebe-Fehling, Erhard; Porter, Brian; Gaillez, Corine; Deodhar, Atul
强直性脊柱炎
免疫/内分泌
发表日期：2021
文献求助 收藏

Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US

美国类风湿性关节炎患者中可能与 Janus 激酶抑制剂相互作用的药物处方频率

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-020-00275-8
Walton, Alison; Paik, Jim; Quebe, Amanda; Kannowski, Carol L; Choong, Casey; Anderson, Seth; Owensby, Justin K
信号转导
关节炎
发表日期：2021
文献求助 收藏

Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study

巴瑞替尼每日一次 2 mg 治疗活动性类风湿关节炎患者的长期疗效：两项为期 24 周的 III 期随机对照研究和一项长期扩展研究的事后分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-021-00317-9
Wells, Alvin F; Jia, Bochao; Xie, Li; Valenzuela, Guillermo J; Keystone, Edward C; Li, Zhanguo; Quebe, Amanda K; Griffing, Kirstin; Otawa, Susan; Haraoui, Boulos
关节炎
发表日期：2021
文献求助 收藏

Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis

美国商业保险类风湿性关节炎患者肾功能损害患病率：一项回顾性分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-021-00346-4
Giles, Jon T; Simon, Lee S; Pope, Janet; Paik, Jim S; Grabner, Michael; Quebe, Amanda; Kannowski, Carol L; Salinas, Claudia A; Curtis, Jeffrey R
关节炎
发表日期：2021
文献求助 收藏

Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1

司库奇尤单抗对强直性脊柱炎患者骨密度和骨转换生物标志物的影响：一项3期研究（MEASURE 1）的2年数据

期刊:BMC Musculoskeletal Disorders
影响因子:2.4
doi:10.1186/s12891-021-04930-1
Braun, Jürgen; Buehring, Bjoern; Baraliakos, Xenofon; Gensler, Lianne S; Porter, Brian; Quebe-Fehling, Erhard; Haemmerle, Sibylle
强直性脊柱炎
免疫/内分泌
发表日期：2021
文献求助 收藏